Semaglutide vs Tirzepatide
GLP-1 only vs GLP-1 + GIP. The difference in mechanism and why it matters for research.
What is the difference
Semaglutide and tirzepatide are both metabolic peptides with GLP-1 activity, but tirzepatide adds a second receptor, GIP. This makes their research profiles distinct. Semaglutide has a longer published record; tirzepatide has proven the dual-agonist approach works outside the lab.
| Property | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 receptor agonist (single) | GLP-1 + GIP dual agonist |
| Developer | Novo Nordisk (approved in branded medicines) | Eli Lilly (approved in branded medicines) |
| Common formats | 5 mg lyophilized powder | 15 mg / 20 mg lyophilized powder |
| Published record | Extensive clinical data spanning years | Growing body of trial and post-market data |
| VND price (this catalog) | 1,100,000 VND | from 1,200,000 VND |
Bottom line
The choice of research material depends on the research question: single-receptor agonism or dual. Both are available. Check availability for your protocol.
Ask about Semaglutide or Tirzepatide
Format, price and timing confirmed before payment. Free swabs + syringe with every order.
Common questions
Which of these peptides is better for research?
Neither is "better": Semaglutide and Tirzepatide address different research questions through different mechanisms. The choice depends on the research protocol.
Can I order both peptides from this catalog?
Yes. Semaglutide and Tirzepatide are listed as separate items. 2+ peptides = free bacteriostatic water 3 ml. Price and availability confirmed before payment.
Do I need a separate inquiry for each peptide?
No. You can ask about both in one Telegram message. Mention the names and formats and the manager will confirm availability, total and timing.